Bipolar Disorder Journal Articles

• Overdose Risk With Co-prescription of Antipsychotics, Opioids This study evaluated the risk of overdose in patients co-prescribed opioids and antipsychotic agents with sedating vs nonsedating properties.
  Schizophrenia Bulletin, May 16, 2022
• Effect of a Novel Nasal Oxytocin Spray on Autism Does this novel intranasal oxytocin spray prove to be an effective therapy for the core social symptoms of autism?
  Brain, May 13, 2022
• Transcranial Alternating Current Stimulation for Depression This study assessed the efficacy of transcranial alternating current stimulation on first-episode drug-naive patients with major depressive disorder.
  Brain, May 05, 2022
• Antipsychotics Associated With Severe Asthma Exacerbation Risk Asthma patients receiving typical antipsychotic treatment may realize a higher risk of severe asthma exacerbations, but the effect may be dose related.
  BMC Pulmonary Medicine, April 27, 2022
• A Pilot Study of Cognition Among Hypoparathyroid Adults A new study aims to provide insights into the possible association between hypoparathyroidism and cognitive impairments.
  Journal of the Endocrine Society, March 29, 2022
• CBT for Prodromal Stage of Psychosis This study assessed the impact of cognitive-behavioral therapy for psychosis on young people at clinically high risk. Can it improve transition rates and psychotic symptoms?
  Schizophrenia Bulletin, March 14, 2022
• Update on ERAS Pathways for Hip and Knee Arthroplasty Get up-to-date on the most current ERAS pathways and guidelines for total hip and knee arthroplasty.
  Current Orthopaedic Practice, March 10, 2022
• Neuropsychiatric Manifestations of Thyroid Disease Learn more about the cognitive and psychiatric disorders associated with thyroid dysfunction and the pathophysiology behind these manifestations.
  Journal of the Endocrine Society, March 01, 2022
• Mindfulness-based Stress Reduction, CT, and BT for Chronic Pain This study compared cognitive therapy, mindfulness-based stress reduction, and behavior therapy in people with chronic low back pain. Did any one technique show superiority over the others?
  Pain, February 07, 2022
• Neuropsychiatric Manifestations of COVID-19 This review synthesizes the neuropsychiatric manifestations of COVID-19 infection in people with psychiatric disorders. What are the most common neuropsychiatric sequelae affecting these patients?
  Journal of Medical Case Reports, February 01, 2022
• Neuroimaging Genomics in Autism and Schizophrenia Find out how neuroimaging genomics could help advance our understanding of the genetic and neuropsychiatric variants associated with these conditions.
  Brain, September 14, 2021
• Pharmacokinetics and DDIs of Preventive Migraine Therapies Review the pharmacokinetics of the most frequently used classes of migraine preventives, and the clinical implications of drug-drug interactions with the use of these therapies in migraine management.
  Headache, August 16, 2021
• Effect of Inadequate Sleep on Frequent Mental Distress Up to one-third of US adults report sleeping less than the recommended amount. Is there a bi-directional relationship between inadequate sleep and mental distress?
  Preventing Chronic Disease, July 23, 2021
• Cannabinoid-based Medications for Pain The popularity of cannabinoid-based medications for treating chronic pain is growing, but the interest in their use may be outpacing the evidence supporting their analgesic benefits
  Current Psychiatry, July 15, 2021
• Lifestyle and Comorbidities in Patients With Migraine This study aimed to compare the prevalence of unhealthy lifestyle factors and comorbid diseases between patients with migraine and migraine-free controls.
  Headache, July 05, 2021
• Neurogranin as a Novel Biomarker in Alzheimer's Disease This study evaluated the diagnostic value of CSF neurogranin and alpha-synuclein as biomarkers of synapsis damage in patients with Alzheimer disease.
  Laboratory Medicine, April 26, 2021
• A Review of Multimodal Hallucinations Review current thought on multimodal hallucinations--hallucinatory experiences which occur in multiple sensory systems. How prevalent are they, and what are their clinical implications?
  Schizophrenia Bulletin, April 16, 2021
• Brief Psychotic Disorder During COVID-19 Pandemic Might the intense psychosocial stress associated with a novel, potentially fatal disease along with lockdown restrictions be a trigger for first-episode psychosis?
  Schizophrenia Bulletin, March 16, 2021
• Pediatric Psoriasis Comorbidities This case presentation highlights the many comorbidities that can manifest in children with psoriasis, including juvenile psoriatic arthritis, uveitis, and metabolic disorders.
  Skin Therapy Letter, February 16, 2021
• Chronic Disease Among African American Families This review summarizes research examining chronic conditions among multiple members of African American families with the aim of increasing understanding of the burden caused family comorbidity.
  Preventing Chronic Disease, January 19, 2021